fatty liver
Conditions
Interventions
None listed
Sponsors
Saga-Ken Medical Centre Koseikan
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with fatty liver disease
Exclusion criteria
Exclusion criteria: patient who cannot declare informed-consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Consistency between the Quenching probe method and the Direct sequence method | — |
Countries
Japan
Contacts
Public ContactYasunori Kawaguchi
Saga-Ken Medical Centre Koseikan Department of Hepatobiliary and Pancreatology
Outcome results
None listed